ERIC ARNETT: Open Payments
NPI 1205235363 · OWASSO, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,026 in 109 payments from 21 companies in 2025. Trend: 2023 $1,970 · 2024 $1,850 · 2025 $2,026
Food & beverage: $2,026
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $332 |
| PFIZER INC. | 17 | $288 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $189 |
| AstraZeneca Pharmaceuticals LP | 5 | $163 |
| ABBVIE INC. | 11 | $151 |
| Astellas Pharma US Inc | 5 | $141 |
| Lilly USA, LLC | 11 | $138 |
| Sumitomo Pharma America, Inc. | 5 | $92 |
| Abbott Laboratories | 2 | $90 |
| GlaxoSmithKline, LLC. | 5 | $79 |
Products named: CAPLYTA, Ozempic, Veozah, NURTEC ODT, ELIQUIS, MOUNJARO, AIRSUPRA, GEMTESA.
Industry payments across OK — which companies pay providers there.
